Literature DB >> 2114369

Infections after auxiliary partial liver transplantation. Experiences in the first ten patients.

J H van Zeijl1, A C Kroes, H J Metselaar, P J Willemse, H A Bruining, J F Sluiters, S W Schalm, O T Terpstra, M F Michel.   

Abstract

In ten auxiliary partial liver transplant recipients selective bowel decontamination (SBD) was used to reduce infections due to gram-negative microorganisms and fungi. During SBD no gram-negative infections occurred. Candida peritonitis was observed in one patient. After discontinuation of SBD serious infections of gram-negative origin did occur and three fungal infections were seen. SBD seems to have a favourable effect in reducing infections by gram-negative microorganisms and fungi. Most striking was the number of enterococcal infections that occurred. Five out of ten patients developed enterococcal infections which in two cases contributed to a fatal outcome. These infections occurred after increase of the number of enterococci in faeces and concomitant positive cultures of bile, ascites or wound drains. This increase could be due to the use of SBD. Also, the kind of biliary anastomosis may play an important role in the relatively high incidence of enterococcal infections. In the postoperative period, recurrence of hepatitis B infection in the liver graft was observed in all patients with cirrhosis due to this virus. Problems caused by other viral infections or protozoal infections remained limited in these ten patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114369     DOI: 10.1007/bf01642102

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  31 in total

1.  Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease.

Authors:  A S Fox; M D Tolpin; A L Baker; C E Broelsch; P F Whittington; T Jackson; J R Thistlethwaite; F P Stuart
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

2.  Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation.

Authors:  J Rakela; R H Wiesner; H F Taswell; P E Hermans; T F Smith; J D Perkins; R A Krom
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

Review 3.  Liver transplantation: an overview.

Authors:  W C Maddrey; D H Van Thiel
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

4.  Selective bowel decontamination to prevent gram-negative bacterial and fungal infection following orthotopic liver transplantation.

Authors:  R H Wiesner; P Hermans; J Rakela; J Perkins; J Washington; S DiCecco; R A Krom
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

5.  Difficult streptococci.

Authors:  R E Warren
Journal:  J Hosp Infect       Date:  1988-02       Impact factor: 3.926

6.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

7.  Enterococcal superinfection and colonization with aztreonam therapy.

Authors:  P H Chandrasekar; B R Smith; J L LeFrock; B Carr
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

9.  Reactivation of hepatitis b after transplantation operations.

Authors:  J Nagington
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

10.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

View more
  1 in total

1.  Microbiological efficacy and pharmacokinetics of prophylactic antibiotics in liver transplant patients.

Authors:  P M Arnow; K Furmaga; J P Flaherty; D George
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.